Evidence map›Paper›PMID 35740189›Full record

ArticleAntibiotics (Basel, Switzerland)2022

18β-Glycyrrhetinic Acid Induces Metabolic Changes and Reduces

Alan J Weaver, Timothy R Borgogna, Galen O'Shea-Stone, Tami R Peters, Valérie Copié, Jovanka Voyich, Martin Teintze

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Alan J WeaverDepartment of Chemistry & Biochemistry, Montana State University, Bozeman, MT 59717, USA.ORCID 0000-0002-9266-0123
Timothy R BorgognaDepartment of Microbiology & Cell Biology, Montana State University, Bozeman, MT 59717, USA.
Galen O'Shea-StoneDepartment of Chemistry & Biochemistry, Montana State University, Bozeman, MT 59717, USA.ORCID 0000-0002-3499-6606
Tami R PetersDepartment of Chemistry & Biochemistry, Montana State University, Bozeman, MT 59717, USA.
Valérie CopiéDepartment of Chemistry & Biochemistry, Montana State University, Bozeman, MT 59717, USA.ORCID 0000-0002-2778-1463
Jovanka VoyichDepartment of Microbiology & Cell Biology, Montana State University, Bozeman, MT 59717, USA.
Martin TeintzeDepartment of Chemistry & Biochemistry, Montana State University, Bozeman, MT 59717, USA.ORCID 0000-0001-7104-1780
Montana State University · US

Funding

Tracking and Evaluation CoreU54GM115371 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI HARMSEN, ALLEN G · 2016 to 2020
$20.9M
Metabolic Control of gut-brain axis in Familial dysautonomia Supplement to parent grant 1R01DK117473-01A1 to support a PhD candidate/graduate student from an under-represented minorityR01DK117473 · NIDDK · MONTANA STATE UNIVERSITY - BOZEMAN · PI COPIE, VALERIE, WALK, SETH T · 2018 to 2022
$3.0M
Acquisition of a 600 MHz NMR cryoprobe and 600 MHz spectrometer console upgradeS10RR026659 · NCRR · MONTANA STATE UNIVERSITY - BOZEMAN · PI COPIE, VALERIE · 2011 to 2011
$600k
Sensing and Adapting to the Neutrophil: SaeR/S Dependent Evasion Strategies Used by Staphylococcus aureusR56AI135039 · NIAID · MONTANA STATE UNIVERSITY - BOZEMAN · PI VOYICH, JOVANKA M · 2018 to 2018
$373k
M J Murdock Charitable Trust 2015066:MNLMontana University System Research Initiative 51040-MUSRI2015-03National Science Foundation MRI:CHE-2018388 and MRI:DBI-1532078NCRR NIH HHS S10 RR026659NIH HHS 1R56AI135039-01A1NIH HHS 1S10RR026659 and 1S10RR13878NIH HHS DK117473NIH HHS U54GM115371
6 · The paper itself

Abstract

The rise in bacterial resistance to common antibiotics has raised an increased need for alternative treatment strategies. The natural antibacterial product, 18β-glycyrrhetinic acid (GRA) has shown efficacy against community-associated methicillin-resistant

Indexed as

antibacterialsantibioticsbiofilm infectionsmetabolomicsMRSAnuclear magnetic resonanceplanktonic cell culturesresistanceStaphylococcus aureusstaphyloxanthin

Identifiers

PMID35740189
PMCPMC9220049
OpenAlexW4281662880

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.